Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Actually, I am no longer in either CXR or HLTH....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by TraderBenon Mar 17, 2017 6:56pm
109 Views
Post# 25996199

RE:RE:Actually, I am no longer in either CXR or HLTH....

RE:RE:Actually, I am no longer in either CXR or HLTH....





Concordia Healthcare Cor (CXR.TO) TSX

2.53 -0.10 (-3.80%) 03/17/17
BARCHART OPINION for Fri, Mar 17th, 2017
 Set Alerts
 
 Watchlist

Overall Average:

88%  SELL

Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities